Hence, Ozempic (semaglutide) is considered safe for humans but should be used in caution with those with a history of medullary thyroid tumours
Its primary outcomes measure is time to first occurrence of any component event of a composite endpoint comprising all-cause death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularization, or heart failure events that result in hospitalization or urgent hospital visits
During semaglutide treatment, repeat TSH testing every 8-12 weeks for the first 6 months, then every 6 months once stable, ensures your existing thyroid medication dose remains appropriate
Magnesium quickly reduces inflammation and muscle pain
When switching, verify that your compounded dose matches the branded dose you were on